Cargando…
Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy?
Combinatory treatments using surgery, radiotherapy and/or chemotherapy together with immunotherapy have shown encouraging results for specific subsets of tumors, but a significant proportion of tumors remains unsusceptible. Some of these inconsistencies are thought to be the consequence of an immuno...
Autores principales: | van Schaik, Thijs A., Chen, Kok-Siong, Shah, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204251/ https://www.ncbi.nlm.nih.gov/pubmed/34141622 http://dx.doi.org/10.3389/fonc.2021.678562 |
Ejemplares similares
-
Anesthesia and Oncology: Friend or Foe?
por: Buddeberg, Bigna S., et al.
Publicado: (2022) -
Malignancy and IFITM3: Friend or Foe?
por: Rajapaksa, Ushani S., et al.
Publicado: (2020) -
Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?
por: Yan, Cong, et al.
Publicado: (2019) -
Editorial: Anesthesia and cancer: Friend or foe?
por: Bezu, Lucillia, et al.
Publicado: (2022) -
Caspase-8: Friend or Foe in Bortezomib/Lenalidomide-Based Therapy for Myeloma
por: Zhou, Liang
Publicado: (2022)